With over 18 years of progressive leadership in oncology nursing, Dr. Lindsey Zinck is a nationally recognized executive known for designing and scaling innovative cancer care delivery models. She holds a PhD in Nursing with a research focus on care delivery transformation, blending deep clinical expertise with operational leadership and a passion for healthcare innovation and technology.

Dr. Zinck most recently served as Chief Nursing Officer of the Abramson Cancer Center at the University of Pennsylvania Health System, where she led system-wide initiatives to improve patient outcomes, clinician experience, and operational performance across complex academic and ambulatory environments. In January 2026, she joined Memorial Sloan Kettering Cancer Center as Vice President of Ambulatory Nursing.

Her leadership portfolio includes the launch of a seven-day ambulatory infusion model to reduce emergency department utilization and preserve inpatient capacity, as well as co-leading one of the nation’s first implementations of Cancer Care @ Home—a program delivering anticancer therapy in patients’ homes to enhance patient experience while optimizing system capacity.

Dr. Zinck’s expertise lies in designing, piloting, and scaling complex care innovations through cross-functional collaboration, data-driven improvement, and stakeholder engagement. She serves as a trusted advisor to digital health companies and innovation teams, including roles as Cancer Program Advisor for Luminate Medical and Leap Health, and as a Nurse Advisory Board member for LeanTaaS, supporting user-centered product development and implementation strategy.

In parallel with her executive leadership, Dr. Zinck holds a faculty appointment at the University of Pennsylvania School of Nursing, where she teaches and mentors emerging leaders at the intersection of care delivery, leadership, and digital transformation. Her work is grounded in a rigorous, patient-centered approach that bridges clinical excellence with scalable, technology-enabled solutions.